Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Baloxavir Marboxil: An Original New Drug against InfluenzaFrançois DufrasnePharmaceuticals (Basel, Switzerland)|January 23, 2024
Immune Diseases: Challenges, Hopes and Recent AchievementsFrançois DufrasnePharmaceutical Patent Analyst|November 19, 2013
Na+/K+-ATPase and cancerTatjana Mijatovic, François Dufrasne, Robert KissSpectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|March 28, 2003
1H-nuclear magnetic resonance determination of the enantiomeric purity of aliphatic primary amines, beta-aminoalcohols, beta-diamines and alpha-amino-acids with 1R-(-)-myrtenal: scope and limitationsFrançois Dufrasne, Michel Gelbcke, Jean NèveExpert Opinion on Therapeutic Patents|June 9, 2020
A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)Jalal Soubhye, Pierre Van Antwerpen, François DufrasneFuture Medicinal Chemistry|November 23, 2016
A survey of the mechanisms of action of anticancer transition metal complexesMickaël Marloye, Gilles Berger, Michel Gelbcke, et al.Pharmaceuticals (Basel, Switzerland)|December 7, 2017
31ièmes Journées Franco-Belges de Pharmacochimie: Meeting ReportRaphaël Frédérick, Lionel Pochet, Pascal De Tullio, et al.Future Medicinal Chemistry|August 1, 2015
Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosisJalal Soubhye, Ibaa Chikh Alard, Pierre van Antwerpen, et al.Current Medicinal Chemistry|June 10, 2016
Myeloperoxidase as a Target for the Treatment of Inflammatory Syndromes: Mechanisms and Structure Activity Relationships of InhibitorsJalal Soubhye, Iyas Aldib, Cédric Delporte, et al.Future Medicinal Chemistry|July 13, 2016
Characterization of chemical features of potent myeloperoxidase inhibitorsJalal Soubhye, Franck Meyer, Paul Furtmüller, et al.Pageof 4